Cargando…

Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases

PURPOSE OF REVIEW: The use of biologic therapies has risen exponentially over recent years, allowing for unprecedented disease control within numerous areas of Allergy/Immunology. With this expanded use, awareness and understanding of adverse reactions to biologic agents have also increased. RECENT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Timothy G., Franzblau, Lauren E., Khan, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Anaphylaxis and Drug Allergy (M Castells, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614199/ https://www.ncbi.nlm.nih.gov/pubmed/36306059 http://dx.doi.org/10.1007/s11882-022-01048-9

Ejemplares similares

Utilizing Biologics in Drug Desensitization
por: Yang, Barbara C., et al.
Publicado: (2022)

Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists
por: Gulen, Theo, et al.
Publicado: (2021)

Component resolved diagnostics for hymenoptera venom allergy
por: Jakob, Thilo, et al.
Publicado: (2017)

Hypersensitivity Reactions to Biologicals: from Bench to Bedside
por: Akarsu, Aysegul, et al.
Publicado: (2020)

Cardiovascular changes during peanut-induced allergic reactions in human subjects
por: Ruiz-Garcia, Monica, et al.
Publicado: (2021)

Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort
por: Nicoletti, Paola, et al.
Publicado: (2021)

Safety of live attenuated influenza vaccine in atopic children with egg allergy
por: Turner, Paul J., et al.
Publicado: (2015)

Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children
por: Santos, Alexandra F., et al.
Publicado: (2014)

Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
por: Brough, Helen A., et al.
Publicado: (2014)

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis
por: Korosec, Peter, et al.
Publicado: (2017)

Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis
por: Patel, Nandinee, et al.
Publicado: (2021)

Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut
por: Santos, Alexandra F., et al.
Publicado: (2015)

The specialty of allergy and clinical immunology in Brazil
por: de Mello, Luane Marques, et al.
Publicado: (2022)

Mast Cell Clonal Disorders: Classification, Diagnosis and Management
por: Onnes, Merel C., et al.
Publicado: (2016)

Idiopathic Anaphylaxis
por: Nwaru, Bright I., et al.
Publicado: (2017)

Management of Anaphylaxis During the SARS-CoV-2 Pandemic
por: Brar, Kanwaljit K., et al.
Publicado: (2021)

Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity
por: Amoah, Abena S., et al.
Publicado: (2013)

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet
por: Srinivasan, Bharani, et al.
Publicado: (2015)

Enquiring About Tolerance (EAT) study: Feasibility of an early allergenic food introduction regimen
por: Perkin, Michael R., et al.
Publicado: (2016)

Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012
por: Turner, Paul J., et al.
Publicado: (2015)

IgG(4) inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens
por: Santos, Alexandra F., et al.
Publicado: (2015)

The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge
por: Caubet, Jean-Christoph, et al.
Publicado: (2011)

Adverse Reactions to Anti-Infective Vaccines: an Emerging Problem in the COVID-19 Era
por: Escudero, Carmelo, et al.
Publicado: (2022)

New Challenges in Drug Allergy: the Resurgence of Excipients
por: Venturini Díaz, Mónica, et al.
Publicado: (2022)

The clinical and immunological basis of early food introduction in food allergy prevention
por: Nuyttens, L., et al.
Publicado: (2023)

Latest Developments in the Management of Nut Allergies
por: Brough, H. A., et al.
Publicado: (2021)

Editorial: Diagnosis and management of allergy to chemotherapy and biologics
por: Madrigal-Burgaleta, Ricardo, et al.
Publicado: (2023)

Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
por: Atanasio, Amanda, et al.
Publicado: (2022)

Editorial: Adverse Vaccine Reactions
por: Terreehorst, Ingrid
Publicado: (2022)

A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE?
por: St. Clair, B., et al.
Publicado: (2021)

Patients’ Perspectives and Needs on Novel Food Allergy Treatments in the United States
por: Herbert, Linda, et al.
Publicado: (2021)

Expertise in Allergy and Immunology Can Aid Other Medical Specialties
por: Johansson, S Gunnar O
Publicado: (2009)

Allergy and Immunotherapy During the Pandemic
por: Davis, Elizabeth Mahoney
Publicado: (2022)

The Economic Burden of Food Allergy: What We Know and What We Need to Learn
por: Fong, Andrew T., et al.
Publicado: (2022)

Editorial: Assessment and management of adverse drug reactions in oncology
por: Tsai, Ping-Feng, et al.
Publicado: (2023)

Drug allergy evaluation in children with suspected mild antibiotic allergy
por: Kitsos, Nikolaos, et al.
Publicado: (2022)

The hygiene hypothesis for allergy – conception and evolution
por: Perkin, Michael R, et al.
Publicado: (2022)

Editorial: Itch and Allergy
por: Misery, Laurent
Publicado: (2021)

Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) consensus statements for penicillin allergy testing by nonallergists
por: Li, Philip H., et al.
Publicado: (2022)

Chitinases: Therapeutic Scaffolds for Allergy and Inflammation
por: Madan, Kirtika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m5ilrdpjdmo28p8sap3uoij6b5